Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Shen Hui Min, Wang Lei, Chen Jia Jun, Zhang Shao Yan, Yang Xu Guang, Zhang Tong, Zheng Pei Yong, Lu Zhen Hui & Huang Xing. (2023) Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy. Expert Opinion on Investigational Drugs 32:8, pages 723-739.
Read now
Read now
Khushwant S. Yadav, Archana Upadhya & Ambikanandan Misra. (2021) Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers). Expert Opinion on Drug Delivery 18:1, pages 103-118.
Read now
Read now
Ming Jing, Xiao-Jie Bi, Xue-Min Yao, Fuyi Cai, Jing-Jing Liu, Min Fu, Liang Kong, Xin-Ze Liu, Lu Zhang, Si-Yu He, Lian-Qun Jia & Xue-Tao Li. (2020) Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis. Drug Development and Industrial Pharmacy 46:4, pages 621-634.
Read now
Read now
Hong-Jun Xie, Jing Zhao, DongZhi Zhuo-Ma, NorBu Zhan-Dui, Aga Er-Bu & Tashi Tsering. (2019) Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3465-3477.
Read now
Read now
Xue-Tao Li, Wei Tang, Hong-Jun Xie, Shuang Liu, Xiao-Li Song, Yao Xiao, Xin Wang, Lan Cheng & Gui-Rong Chen. (2019) The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma. Journal of Liposome Research 29:1, pages 21-34.
Read now
Read now
Xin Wang, Lan Cheng, Hong-Jun Xie, Rui-Jun Ju, Yao Xiao, Min Fu, Jing-Jing Liu & Xue-Tao Li. (2018) Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1154-1169.
Read now
Read now
Rui-Jun Ju, Lan Cheng, Xiao Qiu, Shuang Liu, Xiao-Li Song, Xiao-Ming Peng, Teng Wang, Cui-Qing Li & Xue-Tao Li. (2018) Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. Journal of Drug Targeting 26:9, pages 793-805.
Read now
Read now
Rui-jun Ju, Lan Cheng, Yao Xiao, Xin Wang, Cui-qing Li, Xiao-ming Peng & Xue-tao Li. (2018) PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer. Journal of Liposome Research 28:3, pages 236-248.
Read now
Read now
Xiao-li Song, Rui-jun Ju, Yao Xiao, Xin Wang, Shuang Liu, Min Fu, Jing-jing Liu, Li-yan Gu, Xue-tao Li & Lan Cheng. (2017) Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. International Journal of Nanomedicine 12, pages 7433-7451.
Read now
Read now
Shuang Liu, Xiao-Li Song, Yan-Hong Wang, Xiao-Min Wang, Yao Xiao, Xin Wang, Lan Cheng & Xue-Tao Li. (2017) The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer. Journal of Drug Targeting 25:6, pages 541-553.
Read now
Read now
Articles from other publishers (13)
Subham Das, Shubham Roy, Seikh Batin Rahaman, Saleem Akbar, Bahar Ahmed, Debojyoti Halder, Anu Kunnath Ramachandran & Alex Joseph. (2022) Structure-Activity Relationship Insight of Naturally Occurring Bioactive
Molecules and Their Derivatives Against Non-Small Cell Lung
Cancer: A Comprehensive Review. Current Medicinal Chemistry 29:39, pages 6030-6062.
Crossref
Crossref
Kumari Suganthy Asha, Safia Habib, Moinuddin, Shahid Ali Siddiqui & Asif Ali. (2021) Calf Thymus DNA Exposed to Quinacrine at Physiological Temperatures and pH Acquires Immunogenicity: A Threat for Long Term Quinacrine Therapy. Indian Journal of Clinical Biochemistry 37:4, pages 441-448.
Crossref
Crossref
Bharti Sharma & Dinesh Kumar Yadav. (2022) A systematic review on Drug Re-profiling/Re-Purposing. IARS International Research Journal 12:02.
Crossref
Crossref
Krishan Kumar & Ruchi Chawla. (2021) Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer. Journal of Drug Delivery Science and Technology 65, pages 102677.
Crossref
Crossref
Biswajit Das & Chanakya N. Kundu. (2021) Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle. Anti-Cancer Agents in Medicinal Chemistry 21:4, pages 416-427.
Crossref
Crossref
Christopher Woodman, Gugulethu Vundu, Alex George & Cornelia M. Wilson. (2021) Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Seminars in Cancer Biology 69, pages 349-364.
Crossref
Crossref
Merve Karpuz, Mine Silindir-Gunay, A. Yekta Ozer, Suleyman Can Ozturk, Hamdullah Yanik, Murat Tuncel, Cisel Aydin & Gunes Esendagli. (2021) Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer. European Journal of Pharmaceutical Sciences 156, pages 105576.
Crossref
Crossref
Jigar D. Vanza, Rashmin B. Patel & Mrunali R. Patel. (2020) Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 60, pages 102070.
Crossref
Crossref
Bhuvaneshwar Vaidya, Nishant S. Kulkarni, Snehal K. Shukla, Vineela Parvathaneni, Gautam Chauhan, Jenna K. Damon, Apoorva Sarode, Jerome V. Garcia, Nitesh Kunda, Samir Mitragotri & Vivek Gupta. (2020) Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics. International Journal of Pharmaceutics 577, pages 118995.
Crossref
Crossref
Nitesh Kumar, Varsha Gautam, Varun Kumar & Pawan Kumar Maurya. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
227
259
.
Paulina Skupin-Mrugalska. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
123
160
.
Hongru Yan, Anning Bian, Xiaoge Gao, Huiqin Li, Zetian Chen & Xiangye Liu. (2018) Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine. Future Oncology 14:15, pages 1511-1520.
Crossref
Crossref
Xiao-li Song, Shuang Liu, Ying Jiang, Li-yan Gu, Yao Xiao, Xin Wang, Lan Cheng & Xue-tao Li. (2017) Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG 2000 -transferrin in treatment of brain glioma. European Journal of Pharmaceutical Sciences 96, pages 129-140.
Crossref
Crossref